APA (7th ed.) Citation

Vitiello, P. P., Martini, G., Mele, L., Giunta, E. F., De Falco, V., Ciardiello, D., . . . Martinelli, E. (2021). Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer. Journal of Experimental & Clinical Cancer Research (17569966), 40(1), 1. https://doi.org/10.1186/s13046-020-01811-8

Chicago Style (17th ed.) Citation

Vitiello, Pietro Paolo, et al. "Vulnerability to Low-dose Combination of Irinotecan and Niraparib in ATM-mutated Colorectal Cancer." Journal of Experimental & Clinical Cancer Research (17569966) 40, no. 1 (2021): 1. https://doi.org/10.1186/s13046-020-01811-8.

MLA (9th ed.) Citation

Vitiello, Pietro Paolo, et al. "Vulnerability to Low-dose Combination of Irinotecan and Niraparib in ATM-mutated Colorectal Cancer." Journal of Experimental & Clinical Cancer Research (17569966), vol. 40, no. 1, 2021, p. 1, https://doi.org/10.1186/s13046-020-01811-8.